Annual Retained Earnings
-$2.56 B
-$642.35 M-33.49%
31 December 2023
Summary:
BridgeBio Pharma annual retained earnings is currently -$2.56 billion, with the most recent change of -$642.35 million (-33.49%) on 31 December 2023. During the last 3 years, it has fallen by -$1.12 billion (-78.19%). BBIO annual retained earnings is now -4068.36% below its all-time high of -$61.43 million, reached on 31 December 2017.BBIO Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$2.83 B
-$162.04 M-6.07%
30 September 2024
Summary:
BridgeBio Pharma quarterly retained earnings is currently -$2.83 billion, with the most recent change of -$162.04 million (-6.07%) on 30 September 2024. Over the past year, it has dropped by -$270.71 million (-10.57%). BBIO quarterly retained earnings is now -1477.77% below its all-time high of -$179.44 million, reached on 31 December 2018.BBIO Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BBIO Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -10.6% |
| 3 y3 years | -78.2% | -97.0% |
| 5 y5 years | -481.9% | -543.4% |
BBIO Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.2% | at low | -97.0% | at low |
| 5 y | 5 years | -481.9% | at low | -543.4% | at low |
| alltime | all time | -4068.4% | at low | -1477.8% | at low |
BridgeBio Pharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$2.83 B(+6.1%) |
| June 2024 | - | -$2.67 B(+2.8%) |
| Mar 2024 | - | -$2.60 B(+1.4%) |
| Dec 2023 | -$2.56 B(+33.5%) | -$2.56 B(+7.0%) |
| Sept 2023 | - | -$2.39 B(+8.0%) |
| June 2023 | - | -$2.22 B(+7.7%) |
| Mar 2023 | - | -$2.06 B(+7.3%) |
| Dec 2022 | -$1.92 B(+33.5%) | -$1.92 B(+7.7%) |
| Sept 2022 | - | -$1.78 B(+8.4%) |
| June 2022 | - | -$1.64 B(+0.6%) |
| Mar 2022 | - | -$1.63 B(+13.7%) |
| Dec 2021 | -$1.44 B | -$1.44 B(+11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$1.29 B(+13.8%) |
| June 2021 | - | -$1.13 B(+9.3%) |
| Mar 2021 | - | -$1.04 B(+16.7%) |
| Dec 2020 | -$888.75 M(+102.0%) | -$888.75 M(+15.6%) |
| Sept 2020 | - | -$768.77 M(+17.7%) |
| June 2020 | - | -$652.91 M(+22.8%) |
| Mar 2020 | - | -$531.88 M(+20.9%) |
| Dec 2019 | -$440.03 M(+145.2%) | -$440.03 M(+20.0%) |
| Sept 2019 | - | -$366.57 M(+12.4%) |
| June 2019 | - | -$326.07 M(+38.9%) |
| Mar 2019 | - | -$234.73 M(+30.8%) |
| Dec 2018 | -$179.44 M(+192.1%) | -$179.44 M |
| Dec 2017 | -$61.43 M | - |
FAQ
- What is BridgeBio Pharma annual retained earnings?
- What is the all time high annual retained earnings for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly retained earnings year-on-year change?
What is BridgeBio Pharma annual retained earnings?
The current annual retained earnings of BBIO is -$2.56 B
What is the all time high annual retained earnings for BridgeBio Pharma?
BridgeBio Pharma all-time high annual retained earnings is -$61.43 M
What is BridgeBio Pharma quarterly retained earnings?
The current quarterly retained earnings of BBIO is -$2.83 B
What is the all time high quarterly retained earnings for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly retained earnings is -$179.44 M
What is BridgeBio Pharma quarterly retained earnings year-on-year change?
Over the past year, BBIO quarterly retained earnings has changed by -$270.71 M (-10.57%)